<DOC>
	<DOCNO>NCT01396668</DOCNO>
	<brief_summary>This phase â…¡ trial fix dose rate gemcitabine cisplatin chemotherapy follow chemoradiation capecitabine patient locally advanced pancreatic cancer .</brief_summary>
	<brief_title>Fixed Dose Rate Gemcitabine Cisplatin Followed Chemoradiation Locally Advanced Pancreatic Cancer</brief_title>
	<detailed_description>The main purpose study evaluate efficacy safety fix dose rate gemcitabine cisplatin chemotherapy follow chemoradiation capecitabine patient locally advanced pancreatic cancer .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>unresectable locally advanced pancreatic cancer distant metastasis histologically confirm adenocarcinoma pancreas 1875 age ECOG performance status 02 normal marrow function : WBC least 3,000/mm3 OR Absolute neutrophil count least 1,500/mm3 Platelet count least 100,000/mm3 normal liver function : Bilirubin great 2.0 mg/dL AST le 3 time upper limit normal ( ULN ) normal renal function : Creatinine great 1.5 time ULN sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>locally advanced</keyword>
</DOC>